COVID-19 in people with multiple sclerosis: A global data sharing initiative
Associations of DMT therapies with COVID-19 severity in multiple sclerosis
The MSDA Catalogue: enabling web-based discovery of metadata from real-world multiple sclerosis data sources
A national representative, cross-sectional study by the Hellenic Academy of Neuroimmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: overall impact and willingness towards vaccination
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Updated results of the COVID-19 in MS Global Data Sharing Initiative: anti-CD20 and other risk factors associated with COVID-19 severity
Patient-level dataset to study the effect of COVID-19 in people with Multiple Sclerosis
The journey of data within a Global Data Sharing Initiative: A federated three-layer data analysis pipeline to scale up multiple sclerosis research
Introducing a core dataset for real-world data in multiple sclerosis - recommendations from a global task force
Strategic Oversight Across Real-World Health Data Initiatives in a Complex Health Data Space: A call for collective responsibility